| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-07-20 | NCT07715136 BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT07328581 | BCMA-CD19 cCAR T for the Treatment of Refractory Lupus | Systemic Lupus Erythematosus (SLE) | Not Yet Recruiting |
| NCT07544160 | BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD) | Inflammatory Bowel Diseases (IBD) | Not Yet Recruiting |
| Phase 1 | |||
| NCT06787989 | BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with… | Refractory Immune Cytopenia | Recruiting |
| NCT04162353 | BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma | Multiple Myeloma in Relapse | Recruiting |
| NCT07668557 | Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute… | Acute Myeloid Leukemia (AML) | Recruiting |
| NCT07715136 | BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy | Inflammatory Myopathy | Recruiting |